Literature DB >> 19450338

Bell's palsy.

Julian Holland1.   

Abstract

INTRODUCTION: Bell's palsy is characterised by an acute, unilateral, partial or complete paralysis of the face, which may occur with mild pain, numbness, increased sensitivity to sound, and altered taste. Bell's palsy remains idiopathic, but a proportion may be caused by reactivation of herpes viruses from cranial nerve ganglia. Bell's palsy is most common in people aged 15-40 years, affecting 1 in 60 in their lifetime. Most make a spontaneous recovery within 1 month, but up to 30% have delayed or incomplete recovery. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments in adults and children? We searched: Medline, Embase, The Cochrane Library and other important databases up to February 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found eight systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiviral treatment, corticosteroids (alone or plus antiviral treatment), facial nerve decompression surgery, and mime therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19450338      PMCID: PMC2907944     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  16 in total

Review 1.  Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies.

Authors:  Erik Peitersen
Journal:  Acta Otolaryngol Suppl       Date:  2002

2.  Influence of early high-dose steroid treatment on Bell's palsy evolution.

Authors:  G Lagalla; F Logullo; P Di Bella; L Provinciali; M G Ceravolo
Journal:  Neurol Sci       Date:  2002-09       Impact factor: 3.307

Review 3.  Recent developments in Bell's palsy.

Authors:  N Julian Holland; Graeme M Weiner
Journal:  BMJ       Date:  2004-09-04

4.  Current concepts in neurology: diagnosis and management of facial paralysis.

Authors:  K K Adour
Journal:  N Engl J Med       Date:  1982-08-05       Impact factor: 91.245

5.  Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  P M Grogan; G S Gronseth
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

6.  High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy.

Authors:  Y Furuta; F Ohtani; H Kawabata; S Fukuda; T Bergström
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

7.  Positive effects of mime therapy on sequelae of facial paralysis: stiffness, lip mobility, and social and physical aspects of facial disability.

Authors:  Carien H G Beurskens; Peter G Heymans
Journal:  Otol Neurotol       Date:  2003-07       Impact factor: 2.311

8.  The true nature of Bell's palsy: analysis of 1,000 consecutive patients.

Authors:  K K Adour; F M Byl; R L Hilsinger; Z M Kahn; M I Sheldon
Journal:  Laryngoscope       Date:  1978-05       Impact factor: 3.325

9.  Bell's palsy: a 5 year review of 174 consecutive cases: an attempted double blind study.

Authors:  J S Brown
Journal:  Laryngoscope       Date:  1982-12       Impact factor: 3.325

10.  Outcome of treatment with valacyclovir and prednisone in patients with Bell's palsy.

Authors:  Sara Axelsson; Sven Lindberg; Anna Stjernquist-Desatnik
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-03       Impact factor: 1.547

View more
  1 in total

1.  Acupuncture for sequelae of Bell's palsy: a randomized controlled trial protocol.

Authors:  Hyo-Jung Kwon; Jong-In Kim; Myeong Soo Lee; Jun-Yong Choi; Sungkeel Kang; Jie-Yoon Chung; Young-Jin Kim; Seung-Hoon Lee; Sanghoon Lee; Dongwoo Nam; Yong-Suk Kim; Jae-Dong Lee; Do-Young Choi
Journal:  Trials       Date:  2011-03-09       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.